Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Imalux Corporation was a medical device company that pioneered the use of Optical Coherence Tomography (OCT) for real-time, point-of-care tissue imaging. Its flagship product, the Niris Imaging System, was the first OCT system to receive FDA clearance for medical diagnostics, designed to provide high-resolution cross-sectional views of tissue microstructure. The technology was primarily used as an "optical biopsy" tool in urology and gynecology to help physicians identify cancerous and precancerous lesions without immediate invasive sampling. Based in Cleveland, Ohio, the company's core technology was developed in collaboration with the Institute of Applied Physics of the Russian Academy of Sciences. Although the system achieved commercial status and was used in various clinical settings, the company eventually ceased operations in the early 2010s.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Imalux.